Navdeep S. Chandel, PhD, is an Associate Professor of Pulmonary and Critical Care Medicine and Cell and Molecular Biology at Northwestern University. His research focuses on how mitochondria function as signaling organelles regulating normal physiological functions as well as diseases such as lung injury, lung fibrosis, and lung cancer. He is on the Editorial Board of the journal Oncogene.
Thomas Corbridge, MD, is Professor of Medicine at Northwestern University. His clinical interests include asthma, COPD, acute respiratory failure, and mechanical ventilation. Dr. Corbridge’s research focuses on medical education strategies and outcomes.
John Heffner, MD, is Garnjobst Chair at Providence Portland Medical Center and a Professor of Medicine at the Oregon Health & Science University. His academic interests focus on pleural disease, COPD, education, quality improvement, guideline development, and patient safety. He is a Past President of the American Thoracic Society (ATS) and served for 16 years in various roles for the American Board of Internal Medicine that included chair of the Pulmonary Disease Test Committee and ABIM Executive Committee. Dr. Heffner maintains an active pulmonary practice with The Oregon Clinic.
Robert Kotloff, MD, is the Craig and Elaine Dobbin/Nancy P. Blumenthal Professor of Medicine at the University of Pennsylvania and Chief of the Section of Advanced Lung Disease and Lung Transplantation. In addition to maintaining an active clinical practice and running the Pulmonary/Critical Care Fellowship Program at Penn, Dr. Kotloff’s research work has focused on outcomes following lung transplantation. Dr. Kotloff recently completed a term as Co-Chair of the Pulmonary Disease Test Committee of the American Board of Internal Medicine.
Werner Seeger, MD, is Chief of the Department of Internal Medicine at the University of Giessen Hospital, in Giessen Germany, and serves as both Chairman of the University of Giessen Lung Center, and Director of the Max Planck Institute for Heart and Lung Research. His research has focused on aspects of the pathogenesis of acute lung injury, pulmonary hypertension, lung fibrosis as well as pneumonia and sepsis. He is also actively involved in the development of novel drugs for the treatment of these diseases, in particular, drugs which drive therapeutic reverse-remodelling of affected lungs.
Mary E. Strek, MD, is Professor of Medicine in the section of Pulmonary and Critical Care Medicine and the Committee on Clinical Pharmacology and Pharmacogenomics at the University of Chicago. She is the Director of the Respiratory Clinical Research Program and the Pulmonary Medicine Service. Dr. Strek specializes in the diagnosis and treatment of complex pulmonary disorders with a clinical research interest in connective tissue disease related interstitial lung disease and bronchiectasis. Her research program is devoted to performing clinical trials of new medications for patients with asthma, COPD, bronchiectasis, pulmonary fibrosis and sarcoidosis.